enVVeno Medical Cash from Financing (Quarterly) Analysis

enVVeno Medical Corp (NVNO)

3.33 -0.08 (-2.35%) USD | NASDAQ | Nov 15, 14:30

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
September 30, 2024	13.59M
June 30, 2024	0.00
March 31, 2024	0.046M
December 31, 2023	25.79M
September 30, 2023	0.00
June 30, 2023	0.00
March 31, 2023	0.00
December 31, 2022
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021	-0.004M
September 30, 2021	19.24M
June 30, 2021	0.00
March 31, 2021	38.37M
December 31, 2020	6.347M

Date	Value
September 30, 2020	5.872M
June 30, 2020	2.286M
March 31, 2020	0.5703M
December 31, 2019	0.00
September 30, 2019	0.00
June 30, 2019	3.320M
March 31, 2019	2.317M
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018	7.174M
March 31, 2018	1.857M
December 31, 2017	0.9684M
September 30, 2017	1.381M
June 30, 2017	1.230M
March 31, 2017	0.4789M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.004M

Minimum

Dec 2021

38.37M

Maximum

Mar 2021

7.007M

Average

0.3082M

Median

Cash from Financing (Quarterly) Benchmarks

NeuroOne Medical Technologies Corp	1.560M
SINTX Technologies Inc	1.01M
Nutriband Inc	-0.0051M
Beyond Air Inc	-0.264M
CVRx Inc	40.20M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-4.276M
Cash from Investing (Quarterly)	6.22M
Free Cash Flow	-16.74M
Free Cash Flow Per Share (Quarterly)	-0.2667
Free Cash Flow Yield	-31.57%